Our team

Teaching Assistant Milica Pesic, MD

Academic and scientific position (affiliation)

Education and professional training

Selected publications

  1. Pešić M, Dragašević Mišković N, Marjanović A, Dobričić V, Maksimović N, Svetel M, Perović D, Novaković I, Cirković S, Stanković I, Kostić V. Premutations in the FMR1 gene in Serbian patients with undetermined tremor, ataxia and parkinsonism. Neurol Res. 2021 Apr;43(4):321-326. doi: 10.1080/01616412.2020.1863697. Epub 2021 Jan 6. PMID: 33403926.
  2. Dusanovic Pjevic M, Jekic B, Beslac Bumbasirevic L, Vojvodic L, Damnjanovic T, Grk M, Maksimovic N, Pesic M, Gulic M, Trickovic J, Kacar K. TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic stroke. Pharmacotherapy. 2021 Jul;41(7):562-571. doi: 10.1002/phar.2532. Epub 2021 May 27. PMID: 33942334.
  3. Grk M, Milic V, Dolzan V, Maksimovic N, Damnjanovic T, Pjevic MD, Pesic M, Novakovic I, Jekic B. Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis. Pharmacogenomics J. 2020 Dec;20(6):784-791. doi: 10.1038/s41397-020-0168-z. Epub 2020 May 24. PMID: 32448869.
  4. Dušanović Pjević M, Beslac Bumbaširevic L, Vojvodic L, Grk M, Maksimović N, Damnjanović T, Novaković I, Kačar K, Pesic M, Perovic D, Savic M, Maksic V, Trickovic J, Jekic B. Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy. J Pharm Pharm Sci. 2019;22(1):142-149. doi: 10.18433/jpps30339. PMID: 31013014.

Milica has 4 publications in the international peer–reviewed journals with 13 citations and h–index of 2.

Participation in scientific research projects

Membership in scientific and medical organizations

© 2024 POLYFRAX_Drosophila Project • Web design & development Tacit LLC Sombor